This topic contains a solution. Click here to go to the answer

Author Question: The dosage of cyclosporine would need to be increased if the patient is also receiving: a. ... (Read 143 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
The dosage of cyclosporine would need to be increased if the patient is also receiving:
 
  a. phenytoin.
  b. prednisone.
  c. ketoconazole.
  d. amphotericin B.

Question 2

The physician prescribes sumatriptan for a patient's headache. Before administering this drug, the nurse should gather which assessment information?
 
  a. Does the patient have a family history of migraines?
  b. Has the patient taken ergotamine in the past 24 hours?
  c. Has the patient taken acetaminophen in the past 3 hours?
  d. Is the patient allergic to sulfa compounds?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

yifu223

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

a

Answer to Question 2

b




crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Jul 23, 2018
Excellent


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library